Arena trimmed after panel vote

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) fell $1.76 (47%) to $1.99 on Friday after an FDA panel

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE